InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Mendelsohn Alan, Directeur Médical. Director active across 1 companies, notably Timber Pharmaceuticals, Inc.. Aggregated, 4 filings have been recorded. Total volume traded: €16k. The latest transaction was filed on 23 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€4,18110,000 shares@ €0.418153.9% of flow
Common Stock, par value $0.001 per share
SEC:0000905718-21-001534·
Ideal exit: 20 Aug 2022 (T+270)
€4,18110,000 shares@ €0.418127.0% of flow
Common Stock, par value $0.001 per share
SEC:0000905718-21-001534:0·
Ideal exit: 20 Aug 2022 (T+270)
€3,5701,988 shares@ €1.795546.1% of flow
Common Stock, par value $0.001 per share
SEC:0000905718-21-000665·
Ideal exit: 28 Nov 2021 (T+270)
€3,5701,988 shares@ €1.795523.0% of flow
Common Stock, par value $0.001 per share
SEC:0000905718-21-000665:0·
Ideal exit: 28 Nov 2021 (T+270)
4 of 4 declarations
About Mendelsohn Alan
Alan Mendelsohn is the Chief Medical Officer at Timber Pharmaceuticals, Inc. He is responsible for overseeing the company's medical activities and clinical research. His medical expertise is essential in guiding product development initiatives and ensuring compliance with regulations.
